French nuclear power plants and childhood leukemia
Dose Response
.
2014 Oct 20;12(4):518-21.
doi: 10.2203/dose-response.14-048.Fornalski.
eCollection 2014 Dec.
Authors
Krzysztof W Fornalski
1
,
Mervyn Cohen
2
,
Jerry M Cuttler
3
,
Ludwik Dobrzyński
4
,
Mohan Doss
5
,
Vincent J Esposito
6
,
Ludwig E Feinendegen
7
,
Alan Fellman
8
,
Mark L Miller
9
,
Jane Orient
10
,
Charles W Pennington
11
,
Kanokporn N Rithidech
12
,
Bill Sacks
13
,
Charles L Sanders
14
,
Bobby R Scott
15
,
Jeffry A Siegel
16
,
Yehoshua Socol
17
,
James Welsh
18
Affiliations
1
PGE EJ 1 and Polish Nuclear Society, Poland.
2
Indiana University, USA.
3
Cuttler & Associates, Canada.
4
National Centre for Nuclear Research, Poland.
5
Fox Chase Cancer Center, USA.
6
University of Pittsburgh, USA.
7
Heinrich-Heine University, Germany.
8
Dade Moeller & Associates, USA.
9
Sandia National Laboratories, USA.
10
President of Doctors for Disaster Preparedness, USA.
11
Executive Nuclear Energy Consultant, USA.
12
Stony Brook University, USA.
13
FDA's Center for Devices and Radiological Health (retired), USA.
14
(retired), USA.
15
Lovelace Respiratory Research Institute (retired), USA.
16
Nuclear Physics Enterprises, USA.
17
Falcon Analytics, Israel.
18
Loyola University Chicago - Stritch School of Medicine, USA.
PMID:
25552953
PMCID:
PMC4267445
DOI:
10.2203/dose-response.14-048.Fornalski
No abstract available
Keywords:
Geocap Study; cancer; childhood leukemia; low dose; nuclear power plant; radiation.